In the presented study, an attempt was made to evaluate the changes in UPIIIa and UPII expression in selected urological benign diseases, i.e., BPH, US, UTI and urolithiasis, by measuring the concentration of these proteins in the urine and plasma of patients. Here, UPK2 is linked to urolithiasis.